Anti-SPRY4 monoclonal antibody

Pre-made anti-SPRY4 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SPRY4/SPRY4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1815-Ab-1/ GM-Tg-hg-IP1815-Ab-2Anti-Human SPRY4 monoclonal antibodyHuman
GM-Tg-rg-IP1815-Ab-1/ GM-Tg-rg-IP1815-Ab-2Anti-Rat SPRY4 monoclonal antibodyRat
GM-Tg-mg-IP1815-Ab-1/ GM-Tg-mg-IP1815-Ab-2Anti-Mouse SPRY4 monoclonal antibodyMouse
GM-Tg-cynog-IP1815-Ab-1/ GM-Tg-cynog-IP1815-Ab-2Anti-Cynomolgus/ Rhesus macaque SPRY4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1815-Ab-1/ GM-Tg-felg-IP1815-Ab-2Anti-Feline SPRY4 monoclonal antibodyFeline
GM-Tg-cang-IP1815-Ab-1/ GM-Tg-cang-IP1815-Ab-2Anti-Canine SPRY4 monoclonal antibodyCanine
GM-Tg-bovg-IP1815-Ab-1/ GM-Tg-bovg-IP1815-Ab-2Anti-Bovine SPRY4 monoclonal antibodyBovine
GM-Tg-equg-IP1815-Ab-1/ GM-Tg-equg-IP1815-Ab-2Anti-Equine SPRY4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1815-Ab-1/ GM-Tg-hg-IP1815-Ab-2; GM-Tg-rg-IP1815-Ab-1/ GM-Tg-rg-IP1815-Ab-2;
GM-Tg-mg-IP1815-Ab-1/ GM-Tg-mg-IP1815-Ab-2; GM-Tg-cynog-IP1815-Ab-1/ GM-Tg-cynog-IP1815-Ab-2;
GM-Tg-felg-IP1815-Ab-1/ GM-Tg-felg-IP1815-Ab-2; GM-Tg-cang-IP1815-Ab-1/ GM-Tg-cang-IP1815-Ab-2;
GM-Tg-bovg-IP1815-Ab-1/ GM-Tg-bovg-IP1815-Ab-2; GM-Tg-equg-IP1815-Ab-1/ GM-Tg-equg-IP1815-Ab-2
Products NameAnti-SPRY4 monoclonal antibody
Formatmab
Target NameSPRY4
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SPRY4 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1815-Ag-1Recombinant multi-species SPY4/ SPRY4/ HH17 protein
    ORF Viral VectorvGMLV000759human SPRY4 Lentivirus particle
    ORF Viral VectorpGMLV000759human SPRY4 Lentivirus plasmid


    Target information

    Target IDGM-IP1815
    Target NameSPRY4
    Gene ID81848,24066,291610,705836,487192,101081950,504593,100072121
    Gene Symbol and SynonymsA030006O18Rik,HH17,sprouty4,SPRY4
    Uniprot AccessionQ9C004,A2VDU1
    Uniprot Entry NameSPY4_HUMAN,SPY4_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000187678
    Target ClassificationN/A

    The target: SPRY4, gene name: SPRY4, also named as HH17. This gene encodes a member of a family of cysteine- and proline-rich proteins. The encoded protein is an inhibitor of the receptor-transduced mitogen-activated protein kinase (MAPK) signaling pathway. Activity of this protein impairs the formation of active GTP-RAS. Nucleotide variation in this gene has been associated with hypogonadotropic hypogonadism 17 with or without anosmia. Alternative splicing results in a multiple transcript variants. [provided by RefSeq, Jun 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.